AtoCap closes £700K funding round

AtoCap closed on circa GBP 700K of new funding into the business in late 2020, from a group of investors that includes family office investors and venture investment firm Mustard Seed.

Mustard Seed is a principal investor in world-class early-stage businesses that generate compelling financial and societal returns.

This funding will be pivotal in bringing the company towards its next key milestone: the first-in-human trial of CapFuran® for treatment-resistant urinary tract infection.

Back to news index